Dynamic Metabolic Changes during the First 3 Months after ⁹⁰Y-Ibritumomab Tiuxetan Radioimmunotherapy

Table 1

Patient population characteristic.

Pt	Age at onset (years)	Stage at onset	Number of prior regimens	Age at RIT (years)	Stage at RIT	Days after previous treatment (days)	PET scan
							Baseline	1-week	4-week	12-week
1	60	II	6	76	III	27	◯	◯	n/a	n/a
2	55	III	4	63	I	31	◯	◯	◯	◯
3	48	II	3	61	III	478	◯	◯	◯	◯
4	56	III	2	59	I	68	◯	n/a	◯	◯
5	70	III	3	78	I	87	◯	n/a	◯	◯
6	57	I	4	67	III	90	◯	n/a	◯	◯
7	43	III	4	56	I	143	◯	◯	◯	◯

n/a: not available.